Folate biochemical pathways and their regulation

Folate in Health and Disease, Second Edition

Volumn , Issue , 2009, Pages 49-74

  Stover, Patrick J ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057943345     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (187)

1. Schirch V, Strong WB. Interaction of folylpolyglutamates with enzymes in one-carbon metabolism. Arch Biochem Biophys 1989; 269:371-80.
2. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 1989; 45:263-335.
3. Porter DH, Cook RJ, Wagner C. Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver. Arch Biochem Biophys 1985; 243:396-407.
4. Woeller CF, Anderson DD, Szebenyi DM, Stover PJ. Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway. J Biol Chem 2007; 282:17623-31.
5. Appling DR. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J 1991; 5:2645-51.
6. Scott JM, Dinn JJ, Wilson P, Weir DG. Pathogenesis of subacute combined degeneration: A result of methyl group deficiency. Lancet 1981; 2:334-37.
7. Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr2001; 21:255-82.
8. Miranda TB, Jones PA. DNA methylation: The nuts and bolts of repression. J Cell Physiol 2007; 213:384-90.
9. Winter-Vann AM, Kamen BA, Bergo MO, Young SG, Melnyk S, James SJ, Casey PJ. Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate. Proc Natl Acad Sci USA 2003; 100:6529-34.
10. Stead LM, Jacobs RL, Brosnan ME, Brosnan JT. Methylation demand and homocysteine metabolism. Adv Enzyme Regul 2004; 44:321-33.
11. Meredith M, Rabaglia M, Metz S. Cytosolic biosynthesis of GTP and ATP in normal rat pancreatic islets. Biochim Biophys Acta 1995; 1266:16-22.
12. Brodsky G, Barnes T, Bleskan J, Becker L, Cox M, Patterson D. The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome. Hum Mol Genet 1997; 6:2043-50.
13. An S, Kumar R, Sheets ED, Benkovic SJ. Reversible compartmentalization of de novo purine biosynthetic complexes in living cells. Science 2008; 320:103-06.
14. Aimi J, Qiu H, Williams J, Zalkin H, Dixon JE. De novo purine nucleotide biosynthesis: Cloning of human and avian cDNAs encoding the trifunctional glycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase by functional complementation in E. coli. Nucleic Acids Res 1990; 18:6665-72.
15. Schild D, Brake AJ, Kiefer MC, Young D, Barr PJ. Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations. Proc Natl Acad Sci USA 1990; 87:2916-20.
16. Beardsley GP, Moroson BA, Taylor EC, Moran RG. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. J Biol Chem1989; 264:328-33.
17. Erba E, Sen S, Sessa C, Vikhanskaya FL, D’Incalci M. Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid. Br J Cancer 1994; 69:205-11.
18. Zhao R, Goldman ID. Resistance to antifolates. Oncogene 2003; 22:7431-57.
19. Howard KM, Muga SJ, Zhang L, Thigpen AE, Appling DR. Characterization of the rat cytoplasmic C1-tetrahydrofolate synthase gene and analysis of its expression in liver regeneration and fetal development. Gene 2003; 319:85-97.
20. Christensen KE, MacKenzie RE. Mitochondrial one-carbon metabolism is adapted to the specific needs of yeast, plants and mammals. Bioessays 2006; 28:595-605.
21. Smith GK, Mueller WT, Benkovic PA, Benkovic SJ. On the cofactor specificity of glycinamide ribonucleotide and 5-aminoimidazole-4-carboxamide ribonucleotide transform-ylase from chicken liver. Biochemistry 1981; 20:1241-45.
22. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydro-genase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet 2002; 71:1207-15.
23. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, Capra V. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk. J Hum Genet 2006; 51:98-103.
24. Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O’Leary VB, Pangilinan F, et al. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 2006; 14:768-72.
25. Parle-McDermott A, Mills JL, Kirke PN, Cox C, Signore CC, Kirke S, Molloy AM, et al. MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae. Am J Med Genet A 2005; 132:365-68.
26. Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM, Cotter A, Conley M, et al. A polymorphism in the MTHFD1 gene increases a mother’s risk of having an unexplained second trimester pregnancy loss. Mol Hum Reprod 2005; 11:477-80.
27. Hilton JF, Christensen KE, Watkins D, Raby BA, Renaud Y, de la Luna S, Estivill X, MacKenzie RE, Hudson TJ, Rosenblatt DS. The molecular basis of glutamate formimi-notransferase deficiency. Hum Mutat 2003; 22:67-73.
28. Donato H, Krupenko NI, Tsybovsky Y, Krupenko SA. 10-Formyltetrahydrofolate dehydrogenase requires a 4'-phosphopantetheine prosthetic group for catalysis. J Biol Chem2007; 282:34159-66.
29. Cook RJ, Lloyd RS, Wagner C. Isolation and characterization of cDNA clones for rat liver 10-formyltetrahydrofolate dehydrogenase. J Biol Chem 1991; 266:4965-73.
30. Mackenzie RE. Biogenesis and interconversion of substituted tetrahydrofolates. In: Blakley RL, Benkovic SJ, eds., Folates and Pterins, vol. 1, Chemistry and Biochemistry of Folates. New York: Wiley-Interscience, 1984:255-306.
31. Kim DW, Huang T, Schirch D, Schirch V. Properties of tetrahydropteroylpenta-glutamate bound to 10-formyltetrahydrofolate dehydrogenase. Biochemistry 1996; 35:15772-83.
32. Anguera MC, Field MS, Perry C, Ghandour H, Chiang EP, Selhub J, Shane B, Stover PJ. Regulation of folate-mediated one-carbon metabolism by 10-formyltetrahydrofolate dehydrogenase. J Biol Chem 2006; 281:18335-42.
33. Krupenko SA, Oleinik NV. 10-Formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ 2002; 13:227-36.
34. Oleinik NV, Krupenko SA. Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. Mol Cancer Res 2003; 1:577-88.
35. Champion KM, Cook RJ, Tollaksen SL, Giometti CS. Identification of a heritable deficiency of the folate-dependent enzyme 10-formyltetrahydrofolate dehydrogenase in mice. Proc Natl Acad Sci USA 1994; 91:11338-42.
36. Anguera MC, Liu X, Stover PJ. Cloning, expression, and purification of 5,10-methenyltet-rahydrofolate synthetase from Mus musculus. Protein Expr Purif 2004; 35:276-83.
37. Field MS, Szebenyi DM, Perry CA, Stover PJ. Inhibition of 5,10-methenyltetrahydrofo-late synthetase. Arch Biochem Biophys 2007; 458:194-201.
38. Field MS, Szebenyi DM, Stover PJ. Regulation of de novo purine biosynthesis by meth-enyltetrahydrofolate synthetase in neuroblastoma. J Biol Chem 2006; 281:4215-21.
39. Stover P, Kruschwitz H, Schirch V. Evidence that 5-formyltetrahydropteroylglutamate has a metabolic role in one-carbon metabolism. Adv Exp Med Biol 1993; 338:679-85.
40. Bertrand R, Jolivet J. Methenyltetrahydrofolate synthetase prevents the inhibition of phosphoribosyl 5-aminoimidazole 4-carboxamide ribonucleotide formyltransferase by 5-formyltetrahydrofolate polyglutamates. J Biol Chem 1989; 264:8843-46.
41. Carreras CW, Santi DV. The catalytic mechanism and structure of thymidylate synthase. Annu Rev Biochem 1995; 64:721-62.
42. Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ. Cytoplasmic serine hydroxy-methyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem 2002; 277:38381-89.
43. Ash J, Liao WC, Ke Y, Johnson LF. Regulation of mouse thymidylate synthase gene expression in growth-stimulated cells: Upstream S phase control elements are indistinguishable from the essential promoter elements. Nucleic Acids Res 1995; 23:4649-56.
44. Jenh CH, Geyer PK, Johnson LF. Control of thymidylate synthase mRNA content and gene transcription in an overproducing mouse cell line. Mol Cell Biol 1985; 5:2527-32.
45. Navalgund LG, Rossana C, Muench AJ, Johnson LF. Cell cycle regulation of thymi-dylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem 1980; 255:7386-90.
46. Angus SP, Wheeler LJ, Ranmal SA, Zhang X, Markey MP, Mathews CK, Knudsen ES. Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication. J Biol Chem 2002; 277:44376-84.
47. Powell CM, Rudge TL, Zhu Q, Johnson LF, Hansen U. Inhibition of the mammalian transcription factor LSF induces S-phase-dependent apoptosis by downregulating thymidylate synthase expression. EMBO J 2000; 19:4665-75.
48. Chu J, Dolnick BJ. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim Biophys Acta 2002; 1587:183-93.
49. Chu E, Koeller DM, Casey JL, Drake JC, Chabner BA, Elwood PC, Zinn S, Allegra CJ. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci USA 1991; 88:8977-81.
50. Takemura Y, Jackman AL. Folate-based thymidylate synthase inhibitors in cancer chemotherapy. Anticancer Drugs 1997; 8:3-16.
51. Gorlick R, Metzger R, Danenberg KD, Salonga D, Miles JS, Longo GS, Fu J, et al. Higher concentrations of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol 1998; 16:1465-69.
52. Van der Wilt CL, Pinedo HM, Smid K, Peters GJ. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res 1992; 52:4922-28.
53. Forsthoefel AM, Pena MM, Xing YY, Rafique Z, Berger FG. Structural determinants for the intracellular degradation of human thymidylate synthase. Biochemistry 2004; 43:1972-79.
54. Kitchens ME, Forsthoefel AM, Rafique Z, Spencer HT, Berger FG. Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation. J Biol Chem 1999; 274:12544-47.
55. Hori T, Ayusawa D, Shimizu K, Koyama H, Seno T. Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells. Cancer Res 1984; 44:703-09.
56. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94:3290-95.
57. Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ, Ladner RD. A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 2003; 63:2898-904.
58. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5’-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995; 20:191-97.
59. Kawakami K, Watanabe G. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res2003; 63:6004-07.
60. Krajinovic M, Costea I, Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia. Lancet 2002; 359:1033-34.
61. Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, Warren R, Tsao-Wei D, Groshen S, Lenz HJ. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 2001; 1:65-70.
62. Kawakami K, Omura K, Kanehira E, Watanabe Y. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 1999; 19:3249-52.
63. Lincz LF, Scorgie FE, Garg MB, Ackland SP. Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele. Int J Cancer 2007; 120:1930-34.
64. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD. Searching expressed sequence tag databases: Discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 2000; 9:1381-85.
65. Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lenz HJ, Ladner RD. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics2004; 14:319-27.
66. Volcik KA, Shaw GM, Zhu H, Lammer EJ, Laurent C, Finnell RH. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol 2003; 67:924-28.
67. Tan LU, Drury EJ, MacKenzie RE. Methylenetetrahydrofolate dehydrogenase-meth-enyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase. A multifunctional protein from porcine liver. J Biol Chem 1977; 252:1117-22.
68. Garrow TA, Brenner AA, Whitehead VM, Chen XN, Duncan RG, Korenberg JR, Shane B. Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxy-methyltransferases and chromosomal localization. J Biol Chem 1993; 268:11910-16.
69. Girgis S, Nasrallah IM, Suh JR, Oppenheim E, Zanetti KA, Mastri MG, Stover PJ. Molecular cloning, characterization and alternative splicing of the human cytoplasmic serine hydroxymethyltransferase gene. Gene 1998; 210:315-24.
70. Oppenheim EW, Adelman C, Liu X, Stover PJ. Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis. J Biol Chem2001; 276:19855-61.
71. Anderson DD, Woeller CF, Stover PJ. Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase. Clin Chem Lab Med 2007; 45:1760-63.
72. Strong WB, Schirch V. In vitro conversion of formate to serine: Effect of tetrahydropte-roylpolyglutamates and serine hydroxymethyltransferase on the rate of 10-formyltetra-hydrofolate synthetase. Biochemistry 1989; 28:9430-39.
73. Nijhout HF, Reed MC, Lam SL, Shane B, Gregory JF 3rd, Ulrich CM. In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theor Biol Med Model 2006; 3:40.
74. Scheer JB, Mackey AD, Gregory JF 3rd. Activities of hepatic cytosolic and mitochondrial forms of serine hydroxymethyltransferase and hepatic glycine concentration are affected by vitamin B-6 intake in rats. JNutr 2005; 135:233-38.
75. Perry C, Yu S, Chen J, Matharu KS, Stover PJ. Effect of vitamin B6 availability on serine hydroxymethyltransferase in MCF-7 cells. Arch Biochem Biophys 2007; 462:21-27.
76. Nakshatri H, Bouillet P, Bhat-Nakshatri P, Chambon P. Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells. Gene 1996; 174:79-84.
77. Perry C, Sastry R, Nasrallah IM, Stover PJ. Mimosine attenuates serine hydroxymethyl-transferase transcription by chelating zinc. Implications for inhibition of DNA replication. J Biol Chem 2005; 280:396-400.
78. Woeller CF, Fox JT, Perry C, Stover PJ. A ferritin-responsive internal ribosome entry site regulates folate metabolism. J Biol Chem 2007; 282:29927-35.
79. Kompis IM, Islam K, Then RL. DNA and RNA synthesis: Antifolates. Chem Rev 2005; 105:593-620.
80. Dulucq S, St-Onge G, Gagne V, Ansari M, Sinnett D, Labuda D, Moghrabi A, Krajinovic M. DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood 2008; 111:3692-700.
81. Tai N, Ding Y, Schmitz JC, Chu E. Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition. Nucleic Acids Res 2002; 30:4481-88.
82. Tai N, Schmitz JC, Liu J, Lin X, Bailly M, Chen TM, Chu E. Translational autoregulation of thymidylate synthase and dihydrofolate reductase. Front Biosci 2004; 9:2521-26.
83. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 2004; 124:339-45.
84. Parle-McDermott A, Pangilinan F, Mills JL, Kirke PN, Gibney ER, Troendle J, O’Leary VB, et al. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet A 2007; 143:1174-80.
85. van der Linden IJ, Nguyen U, Heil SG, Franke B, Vloet S, Gellekink H, Heijer M, Blom HJ. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Metab 2007; 91:98-103.
86. Brown SS, Neal GE, Williams DC. Subcellular distribution of some folic acid-linked enzymes in rat liver. Biochem J 1965; 97:34C-36C.
87. Prem veer Reddy G, Pardee AB. Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci USA 1980; 77:3312-16.
88. Samsonoff WA, Reston J, McKee M, O’Connor B, Galivan J, Maley G, Maley F. Intracellular location of thymidylate synthase and its state of phosphorylation. J Biol Chem 1997; 272:13281-85.
89. Wong NA, Brett L, Stewart M, Leitch A, Longley DB, Dunlop MG, Johnston PG, Lessells AM, Jodrell DI. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Br J Cancer 2001; 85:1937-43.
90. Bissoon-Haqqani S, Moyana T, Jonker D, Maroun JA, Birnboim HC. Nuclear expression of thymidylate synthase in colorectal cancer cell lines and clinical samples. J Histochem Cytochem 2006; 54:19-29.
91. Boorstein RJ, Pardee AB. Coordinate inhibition of DNA synthesis and thymidylate synthase activity following DNA damage and repair. Biochem Biophys Res Commun 1983; 117:30-36.
92. Noguchi H, Prem veer Reddy G, Pardee AB. Rapid incorporation of label from ribo-nucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell 1983; 32:443-51.
93. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA, Morgan GJ. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood2002; 99:3786-91.
94. Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003; 88:159-66.
95. Lim U, Peng K, Shane B, Stover PJ, Litonjua AA, Weiss ST, Gaziano JM, et al.Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetra-hydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr 2005; 135:1989-94.
96. Drennan CL, Huang S, Drummond JT, Matthews RG, Lidwig ML. How a protein binds B12: A 3.0 A x-ray structure of B12-binding domains of methionine synthase. Science1994; 266:1669-74.
97. Goulding CW, Postigo D, Matthews RG. Cobalamin-dependent methionine synthase is a modular protein with distinct regions for binding homocysteine, meth-yltetrahydrofolate, cobalamin, and adenosylmethionine. Biochemistry 1997; 36: 8082-91.
98. Peariso K, Huang S, Matthews RG, Penner-Hahn JE. Characterization of the zinc binding site in methionine synthase enzymes of Escherichia coli: The role of zinc in the methylation of homocysteine. J Am Chem Soc 1998; 120:8410-16.
99. Ludwig ML, Matthews RG. Structure-based perspectives on B12-dependent enzymes. Annu Rev Biochem 1997; 66:269-313.
100. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem 1997; 272:3628-34.
101. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62.
102. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet1995; 345:149-51.
103. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine concentrations in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-55.
104. Swanson DA, Liu ML, Baker PJ, Garrett L, Stitzel M, Wu J, Harris M, Banerjee R, Shane B, Brody LC. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 2001; 21:1058-65.
105. Oltean S, Banerjee R. A B12-responsive internal ribosome entry site (IRES) element in human methionine synthase. J Biol Chem 2005; 280:32662-68.
106. Col B, Oltean S, Banerjee R. Translational regulation of human methionine synthase by upstream open reading frames. Biochim Biophys Acta 2007; 1769:532-40.
107. Lassen HC, Henriksen E, Neukirch F, Kristensen HS. Treatment of tetanus: Severe bone-marrow depression after prolonged nitrous-oxide anaesthesia. Lancet 1956; 270:527-30.
108. Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985; 5:115-41.
109. Gulati S, Brody LC, Banerjee R. Posttranscriptional regulation of mammalian methionine synthase by B12. Biochem Biophys Res Commun 1999; 259:436-42.
110. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996; 5:1867-74.
111. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, Peng K, Shane B, Evans AE, Whitehead AS. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999; 17:298-309.
112. Burzynski M, Duriagin S, Mostowska M, Wudarski M, Chwalinska-Sadowska H, Jagodzinski PP. MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Lupus 2007; 16:450-54.
113. Kempisty B, Sikora J, Lianeri M, Szczepankiewicz A, Czerski P, Hauser J, Jagodzinski PP. MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia. Psychiatr Genet 2007; 17:177-81.
114. Doolin MT, Barbaux S, McDonnell M, Hoess K, Whitehead AS, Mitchell LE. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002; 71:1222-26.
115. Mostowska A, Hozyasz KK, Jagodzinski PP. Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population. Clin Genet 2006; 69:512-17.
116. Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003; 121:219-24.
117. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey LB, ed., Folate in Health and Disease. New York: Marcel Dekker, Inc, 1995:23-42.
118. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomo-cysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001; 10:433-43.
119. Kutzbach C, Stokstad EL. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine. Biochim Biophys Acta1971; 250:459-77.
120. Jencks DA, Mathews RG. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J Biol Chem 1987; 262:2485-93.
121. Yamada K, Strahler JR, Andrews PC, Matthews RG. Regulation of human methyl-enetetrahydrofolate reductase by phosphorylation. Proc Natl Acad Sci USA 2005; 102:10454-59.
122. Tran P, Leclerc D, Chan M, Pai A, Hiou-Tim F, Wu Q, Goyette P, Artigas C, Milos R, Rozen R. Multiple transcription start sites and alternative splicing in the methyl-enetetrahydrofolate reductase gene result in two enzyme isoforms. Mamm Genome2002; 13:483-92.
123. van der Velden AW, Thomas AA. The role of the 5’ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 1999; 31:87-106.
124. Pickell L, Tran P, Leclerc D, Hiscott J, Rozen R. Regulatory studies of murine methyl-enetetrahydrofolate reductase reveal two major promoters and NF-kappaB sensitivity. Biochim Biophys Acta 2005; 1731:104-14.
125. Pejchal R, Campbell E, Guenther BD, Lennon BW, Matthews RG, Ludwig ML. Structural perturbations in the Ala --> Val polymorphism of methylenetetrahydrofolate reductase: How binding of folates may protect against inactivation. Biochemistry 2006; 45:4808-18.
126. Shivapurkar N, Tang Z, Frost A, Alabaster O. Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and beta-carotene in rats on a high-risk diet. Cancer Lett 1995; 91:125-32.
127. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999; 6:359-65.
128. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001; 98:14853-58.
129. Kang SS, Wong PW, Zhou JM, Sora J, Lessick M, Ruggie N, Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism1988; 37:611-13.
130. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydro-folate reductase, and plasma homocysteine concentrations. Circulation 1996; 93:7-9.
131. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 1997; 349:1591-93.
132. Parle-McDermott A, Mills JL, Molloy AM, Carroll N, Kirke PN, Cox C, Conley MR, Pangilinan FJ, Brody LC, Scott JM. The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab 2006; 88:290-94.
133. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C-->T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 2002; 288:2023-31.
134. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperho-mocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58:35-41.
135. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, et al.Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95:2032-36.
136. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, et al.Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate concentrations in red blood cells, and risk of neural tube defects. Am J Med Genet 1999; 84:151-57.
137. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP Jr, Adams MJ Jr. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63:610-14.
138. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346:1070-71.
139. Zhu J, Ren A, Hao L, Pei L, Liu J, Zhu H, Li S, Finnell RH, Li Z. Variable contribution of the MTHFR C677T polymorphism to non-syndromic cleft lip and palate risk in China. Am J Med Genet A 2006; 140:551-57.
140. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, Rosendaal FR. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatere-ductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002; 88:723-28.
141. Quere I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daures JP, Schved JF, et al. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: A matched case-control study. Lancet 2002; 359:747-52.
142. Zalavras ChG, Giotopoulou S, Dokou E, Mitsis M, Ioannou HV, Tzolou A, Kolaitis N, Vartholomatos G. Lack of association between the C677T mutation in the 5,10-meth-ylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol 2002; 21:268-71.
143. Lewis SJ, Zammit S, Gunnell D, Smith GD. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet B Neuropsychiatr Genet 2005; 135:2-4.
144. Muntjewerff JW, Hoogendoorn ML, Kahn RS, Sinke RJ, Den Heijer M, Kluijtmans LA, Blom HJ. Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: A Dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 2005; 135:69-72.
145. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: A meta-analysis. Mol Psychiatry 2006; 11:143-49.
146. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, Frants RR, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol2006; 59:372-75.
147. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96:12810-15.
148. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98:4004-09.
149. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56:4862-64.
150. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57:1098-102.
151. Stegmann K, Ziegler A, Ngo ET, Kohlschmidt N, Schroter B, Ermert A, Koch MC. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999; 87:23-29.
152. Stover P, Schirch V. 5-Formyltetrahydrofolate polyglutamates are slow tight binding inhibitors of serine hydroxymethyltransferase. J Biol Chem 1991; 266:1543-50.
153. Horne DW, Patterson D, Cook RJ. Effect of nitrous oxide inactivation of vitamin B12-dependent methionine synthetase on the subcellular distribution of folate coenzymes in rat liver. Arch Biochem Biophys 1989; 270:729-33.
154. Lin BF, Huang RF, Shane B. Regulation of folate and one-carbon metabolism in mammalian cells. III. Role of mitochondrial folylpoly-gamma-glutamate synthetase. J Biol Chem 1993; 268:21674-79.
155. Barlowe CK, Appling DR. Nitrous oxide exposure reduces hepatic C1-tetrahydrofolate synthase expression in rats. Biochem Biophys Res Commun 1988; 157:245-49.
156. Garcia-Martinez LF, Appling DR. Characterization of the folate-dependent mitochondrial oxidation of carbon 3 of serine. Biochemistry 1993; 32:4671-76.
157. Pfendner W, Pizer LI. The metabolism of serine and glycine in mutant lines of Chinese hamster ovary cells. Arch Biochem Biophys 1980; 200:503-12.
158. Titus SA, Moran RG. Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J Biol Chem 2000; 275:36811-17.
159. Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, Shane B, Bailey LB, Gregory JF 3rd. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am J Physiol Endocrinol Metab 2004; 286:E272-79.
160. Chasin LA, Feldman A, Konstam M, Urlaub G. Reversion of a Chinese hamster cell auxotrophic mutant. Proc Natl Acad Sci USA 1974; 71:718-22.
161. Girgis S, Suh JR, Jolivet J, Stover PJ. 5-Formyltetrahydrofolate regulates homocysteine remethylation in human neuroblastoma. J Biol Chem 1997; 272:4729-34.
162. Nikiforov MA, Chandriani S, O’Connell B, Petrenko O, Kotenko I, Beavis A, Sedivy JM, Cole MD. A functional screen for Myc-responsive genes reveals serine hydroxy-methyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 2002; 22:5793-800.
163. Okamura-Ikeda K, Hosaka H, Yoshimura M, Yamashita E, Toma S, Nakagawa A, Fujiwara K, Motokawa Y, Taniguchi H. Crystal structure of human T-protein of glycine cleavage system at 2.0 A resolution and its implication for understanding non-ketotic hyperglycinemia. J Mol Biol 2005; 351:1146-59.
164. Ichinohe A, Kure S, Mikawa S, Ueki T, Kojima K, Fujiwara K, Iinuma K, Matsubara Y, Sato K. Glycine cleavage system in neurogenic regions. Eur J Neurosci 2004; 19:2365-70.
165. Lamers Y, Williamson J, Gilbert LR, Stacpoole PW, Gregory JF 3rd. Glycine turnover and decarboxylation rate quantified in healthy men and women using primed, constant infusions of [1,2-(13)C2]glycine and [(2)H3]leucine. J Nutr 2007; 137: 2647-52.
166. Dinopoulos A, Matsubara Y, Kure S. Atypical variants of nonketotic hyperglycinemia.Mol Genet Metab 2005; 86:61-69.
167. Wittwer AJ, Wagner C. Identification of folate binding protein of mitochondria as dim-ethylglycine dehydrogenase. Proc Natl Acad Sci USA 1980; 77:4484-88.
168. Binzak BA, Wevers RA, Moolenaar SH, Lee YM, Hwu WL, Poggi-Bach J, Engelke UF, Hoard HM, Vockley JG, Vockley J. Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. Am J Hum Genet 2001; 68:839-47.
169. Di Pietro E, Wang XL, MacKenzie RE. The expression of mitochondrial methylenetetra-hydrofolate dehydrogenase-cyclohydrolase supports a role in rapid cell growth. Biochim Biophys Acta 2004; 1674:78-84.
170. Di Pietro E, Sirois J, Tremblay ML, MacKenzie RE. Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development. Mol Cell Biol 2002; 22:4158-66.
171. Peri KG, MacKenzie RE. NAD(+)-dependent methylenetetrahydrofolate dehydrogenase-cyclohydrolase: Detection of the mRNA in normal murine tissues and transcriptional regulation of the gene in cell lines. Biochim Biophys Acta 1993; 1171:281-87.
172. Christensen KE, Patel H, Kuzmanov U, Mejia NR, MacKenzie RE. Disruption of the mthfd1 gene reveals a monofunctional 10-formyltetrahydrofolate synthetase in mammalian mitochondria. J Biol Chem 2005; 280:7597-602.
173. Bianchetti R, Lucchini G, Crosti P, Tortora P. Dependence of mitochondrial protein synthesis initiation on formylation of the initiator methionyl-tRNAf. J Biol Chem 1977; 252:2519-23.
174. Takeuchi N, Kawakami M, Omori A, Ueda T, Spremulli LL, Watanabe K. Mammalian mitochondrial methionyl-tRNA transformylase from bovine liver. Purification, characterization, and gene structure. J Biol Chem 1998; 273:15085-90.
175. Spencer AC, Spremulli LL. Interaction of mitochondrial initiation factor 2 with mitochondrial fMet-tRNA. Nucleic Acids Res 2004; 32:5464-70.
176. van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 2000; 92:57-61.
177. Scott JM. Evidence of folic acid and folate in the prevention of neural tube defects. Bibl Nutr Dieta 2001:192-95.
178. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72:324-32.
179. Gerhard GT, Duell PB. Homocysteine and atherosclerosis. Curr Opin Lipidol 1999; 10:417-28.
180. Lindenbaum J, Allen RH. Clinical spectrum and diagnosis of folate deficiency. In: Bailey LB, ed., Folate in Health and Disease. New York: Marcel Dekker, Inc., 1995:43-73.
181. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. MutatRes 2001; 475:7-20.
182. Choi SW, Mason JB. Folate and carcinogenesis: An integrated scheme. J Nutr 2000; 130:129-32.
183. Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res 1995; 55:1894-901.
184. Kim YI. Folate and cancer prevention: A new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 1999; 57:314-21.
185. Bailey LB. Folate requirements and dietary recommendations. In: Bailey LB, ed., Folate in Health and Disease. New York: Marcel Dekker, Inc, 1995:123-151.
186. McNulty H. Folate requirements for health in different population groups. Br J Biomed Sci 1995; 52:110-19.
187. Scott JM. How does folic acid prevent neural tube defects? Nat Med 1998; 4:895-96.